Clarus Wealth Advisors Immuno Gen, Inc. Transaction History

Clarus Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$2.22 - $3.39 $2,220 - $3,390	-1,000 Closed	0 $0
Q4 2018 Jan 08, 2019	BUY	$3.94 - $9.7 $3,940 - $9,700	1,000 New	1,000 $9,000
Q4 2018 Jan 07, 2019	SELL	$3.94 - $9.7 $3,940 - $9,700	-1,000 Closed	0 $0
Q2 2018 Jul 05, 2018	BUY	$9.52 - $12.15 $9,520 - $12,150	1,000 New	1,000 $11,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.